ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 283168 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 283168; 2) Community: the network communities that were significantly associated with the response to NSC 283168; 3) Molecule: the relationships between components within communities and NSC 283168; 4) MDR: the compounds that were significantly associated with the NSC 283168.

NSC Compound Enrichment Correlation
NSC 658093 Null 0.0152653588725063 0.30306777
NSC 676676 ARQ monoacetate 0.0152653588725063 0.29654972
NSC 682298 Camptothecin Derivative 0.0152653588725063 0.32248237
NSC 694485 Benzoic acid, 4-[[(2,4-diaminopteridinyl)-6-methyl] (formyl)amino]- 0.0152653588725063 0.13221038
NSC 696862 1H-1,4,7-Triazonine-1,4-diacetic acid, octahydro- 0.0152653588725063 0.047744905
NSC 701973 Null 0.0152653588725063 0.27613057
NSC 727223 1-(3-dimethylarsino-3-thio-2-methyl-1-oxopropyl)-L-proline 0.0152653588725063 0.20163303
NSC 727284 2-Bromo-3-methoxy-6-(methylamino)-9,10-dihydrdo-9,10-[1,2]be nzenoanthracene-1,4,5,8-tetraone. 0.0152653588725063 0.25586626
NSC 734148 2-(4-Chloro-benzenesulfonylimino)-imidazolidine-1-carbodithi oic acid 3-thioxo-5,6-dihydro-imidazo[2,1-c][1,2,4] thiadiazol-7-yl ester 0.0152653588725063 0.26612951
NSC 757113 METHOTREXATE(+/-) 0.0152653588725063 0.088887778
Total:25  Current:5    [First] [Prev] [Next] [Last]